Cite
Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India
MLA
Joshi,Shashank, et al. Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1342154266&authtype=sso&custid=ns315887.
APA
Joshi,Shashank, Vora,Agam, Venugopal,K, Dadhich,Pramod, Daxini,Anil, Bhagat,Sagar, Patil,Saiprasad, & Barkate,Hanmant. (2022). Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India.
Chicago
Joshi,Shashank, Vora,Agam, Venugopal,K, Dadhich,Pramod, Daxini,Anil, Bhagat,Sagar, Patil,Saiprasad, and Barkate,Hanmant. 2022. “Real-World Experience with Favipiravir for the Treatment of Mild-to-Moderate COVID-19 in India.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1342154266&authtype=sso&custid=ns315887.